Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum Aminopeptidases, M1, M17 and M18

Malaria is a parasitic disease that remains a global health burden. The ability of the parasite to rapidly develop resistance to therapeutics drives an urgent need for the delivery of new drugs. The Medicines for Malaria Venture have compounds known for their antimalarial activity, but not necessari...

Descripción completa

Detalles Bibliográficos
Autores principales: Paiardini, Alessandro, Bamert, Rebecca S., Kannan-Sivaraman, Komagal, Drinkwater, Nyssa, Mistry, Shailesh N., Scammells, Peter J., McGowan, Sheena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336144/
https://www.ncbi.nlm.nih.gov/pubmed/25700165
http://dx.doi.org/10.1371/journal.pone.0115859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336144/
https://www.ncbi.nlm.nih.gov/pubmed/25700165
http://dx.doi.org/10.1371/journal.pone.0115859

Ejemplares similares